3月24日，绿叶科技集团董事长徐建成携高管团队远赴瑞士巴塞尔，正式拜访拥有129年历史的全球保健 品巨头 LONZA 龙沙集团，双方就健康营养品领域的深度研发、新品落地及国际产业协同展开高层会晤 并达成重要共识。 龙沙集团成立于1897年，总部位于瑞士巴塞尔，2025年销售额达65.31亿瑞士法郎（约 570 亿人民 币），2026年市值约560亿瑞士法郎（约630亿美元），在全球拥有超30个工厂、80+胶囊和剂型专利家 族，服务7000+合作伙伴，是全球营养健康领域的标杆企业。 本次拜访，徐建成董事长一行受到龙沙集团 DFS 营养与商业转型负责人 Moritz Ostermayer、制造部副 总监 Stephan Munier、质量部副主任 Serkan Dag、DFS 和产品开发主管 Chantal Schreiner 等高管的热情 接待。双方回顾了过往合作基础，重点聚焦健康营养品领域的深度研发合作，共商新品研制与规模化生 产落地的国际产业协同布局，标志着绿叶科技与龙沙集团的全球战略合作进入全新阶段。 徐建成董事长表示，龙沙集团是全球营养健康领域的顶尖企业，其领先的技术、严谨的质量体系和全球 化布局，与绿 ...

Core Viewpoint - Lonza has announced the divestment of its Capsules & Health Ingredients (CHI) business to Lone Star Funds, marking a significant step towards becoming a pure-play One Lonza CDMO [2][4]. Group 1: Transaction Details - The agreement involves the sale of 60% of the CHI business to Lone Star Funds, which is a major strategic move for Lonza [4]. - This divestment is part of Lonza's strategy to streamline operations and focus on its core CDMO (Contract Development and Manufacturing Organization) business [4]. Group 2: Company Strategy - Over the past 1.5 years, Lonza has made high-speed progress in creating a focused business model centered around its CDMO operations [4].

Core Viewpoint - Companies across various industries are increasingly adopting a strategy of specialization, focusing on their core competencies while outsourcing non-core functions to enhance efficiency and effectiveness [1]. Group 1 - The trend of specialization is becoming more prevalent among companies, indicating a shift in operational strategies [1]. - Outsourcing is seen as a practical approach for companies to manage resources and streamline operations [1].

Core Insights - The investment environment in 2025 was challenging, with foreign equity markets achieving their best returns in over a decade, while the International Growth Composite Portfolio finished the year essentially flat due to a market preference for cyclically sensitive businesses [8][11]. Portfolio Performance - The International Growth Composite Portfolio's performance was -2.21% for the quarter and 0.68% year-to-date, compared to the MSCI ACWI (ex-USA) which returned 5.05% for the quarter and 32.39% year-to-date [5]. - Top contributors to the Portfolio's performance included Tokyo Electron, ASML, and Shopify, while the largest detractors were Monday.com, MercadoLibre, and SAP [13][17]. Company-Specific Insights - **Tokyo Electron**: A leading player in semiconductor manufacturing equipment, expected to grow revenues at a high single-digit rate and increase operating margins from 25% in 2024 to 35% in the medium term, driving mid-teens earnings growth [14]. - **ASML**: Benefiting from investor optimism around AI, as its equipment is essential for advanced chips, which are critical for AI applications [16]. - **Monday.com**: Despite strong results, the stock sold off due to concerns over near-term growth slowdown, but revenue growth is expected to sustain over 20% as it expands its market reach [18]. - **MercadoLibre**: The largest e-commerce platform in Latin America, experiencing a decline in stock price due to a slight decrease in operating margin while investing in growth initiatives [19]. - **SAP**: Despite cloud revenue growth exceeding expectations, the stock faced pressure due to market conditions, but is viewed as resilient with a strong market position and high recurring revenues [20]. Portfolio Activity - New position established in **Nintendo**, which is expected to see significant growth following the release of the Switch 2, with anticipated earnings growth of 30% annually over the next few years [23]. - Positions in **Teleperformance** and **Siemens Healthineers** were eliminated due to ongoing business challenges, reallocating funds to invest in Nintendo and Tencent [25][26]. Market Outlook - The outlook for the Portfolio remains positive, with expectations of benefiting from structural trends such as technology shifts and growth in emerging markets like India [27].

Core Message - The presentation emphasizes Lonza's strategy for long-term value creation and capital allocation, highlighting its commitment to growth and customer support [2]. Group 1: Company Overview - Lonza operates a leading global Contract Development and Manufacturing Organization (CDMO) network, which positions the company to meet the regionalization needs of its customers' supply chains [2]. - The company is focused on investing across various technologies and regions to support customer growth, which in turn drives Lonza's own growth [2]. Group 2: Financial Model and Business Drivers - The financial model of Lonza is characterized by strong top-line growth and significant investment in growth initiatives [3].

Core Viewpoint - The comparison between Royal Philips (PHG) and Lonza Group Ag (LZAGY) indicates that PHG currently offers better value for investors based on various financial metrics and rankings [1][3][7]. Valuation Metrics - PHG has a forward P/E ratio of 17.92, while LZAGY has a significantly higher forward P/E of 33.33 [5]. - The PEG ratio for PHG is 0.74, indicating a more favorable valuation relative to its expected earnings growth, compared to LZAGY's PEG ratio of 2.06 [5]. - PHG's P/B ratio stands at 2.28, whereas LZAGY's P/B ratio is 4.71, further highlighting PHG's relative undervaluation [6]. Earnings Estimates and Rankings - PHG holds a Zacks Rank of 2 (Buy), suggesting a positive earnings outlook, while LZAGY has a Zacks Rank of 3 (Hold) [3]. - The stronger estimate revision activity for PHG indicates a more favorable earnings outlook compared to LZAGY [7].

Core Viewpoint - The stock price of Lonza Group Ag (LZAGY) has been on a bearish trend, losing 5.4% in the past two weeks, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be increasing [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottom in a downtrend, where the stock opens lower, makes a new low, but then finds support and closes near its opening price, suggesting that bears may be losing control [4][5]. - Hammer candles can appear on various timeframes and are used by both short-term and long-term investors [5]. Fundamental Analysis - There has been a positive trend in earnings estimate revisions for LZAGY, with a 2.6% increase in the consensus EPS estimate over the last 30 days, indicating that analysts expect better earnings than previously predicted [7][8]. - LZAGY holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].

Core Viewpoint - Lonza Group Ag (LZAGY) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are closely correlated with near-term stock price movements [3][5]. - Institutional investors often rely on earnings estimates to determine a company's fair value, leading to buying or selling actions that affect stock prices [3]. Recent Performance and Outlook - For the fiscal year ending December 2025, Lonza Group is projected to earn $1.93 per share, reflecting a 12.9% increase from the previous year [7]. - Over the past three months, the Zacks Consensus Estimate for Lonza Group has risen by 3.2%, indicating a positive trend in earnings expectations [7]. Zacks Rank System - The Zacks Rank system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [6]. - The upgrade of Lonza Group to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, suggesting potential for higher stock movement in the near term [9].

Company Overview - Lonza Group Ag (LZAGY) currently has a Momentum Style Score of B, indicating potential for strong performance based on recent trends [3][12] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned well for future growth [4][12] Price Performance - LZAGY shares have increased by 4.88% over the past week, outperforming the Zacks Medical - Products industry, which rose by 0.94% during the same period [6] - Over the past month, LZAGY's price change is 27.37%, significantly higher than the industry's 4.7% [6] - In the last quarter, shares of LZAGY have risen by 9.64%, and over the past year, they have gained 27.13%, while the S&P 500 has moved -6.46% and 11.69%, respectively [7] Trading Volume - The average 20-day trading volume for LZAGY is 243,543 shares, which serves as a baseline for price-to-volume analysis [8] Earnings Outlook - In the past two months, one earnings estimate for LZAGY has increased, while none have decreased, raising the consensus estimate from $1.87 to $1.89 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions noted [10]

Core Viewpoint - Lonza Group Ag (LZAGY) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates - For the fiscal year ending December 2025, Lonza Group is expected to earn $1.87 per share, reflecting a 9.4% increase from the previous year's reported figure [8]. - Over the past three months, the Zacks Consensus Estimate for Lonza Group has increased by 1.5%, indicating a trend of rising earnings estimates [8]. Zacks Rating System - The Zacks rating system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) to Zacks Rank 5 (Strong Sell), and has a strong track record of performance [7]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, while the next 15% receive a 'Buy' rating, positioning Lonza Group in the top 20% of stocks based on earnings estimate revisions [9][10]. Market Implications - The upgrade to Zacks Rank 2 suggests that Lonza Group's improving earnings outlook could lead to increased buying pressure and a potential rise in stock price [3][5]. - The correlation between earnings estimate revisions and stock price movements highlights the importance of tracking these revisions for investment decisions [6][4].